Results 41 to 50 of about 81,312 (206)

Clinical benefits and considerations of dextromethorphan and bupropion administered separately for managing depression: A case report [PDF]

Mental Health Clinician
MDD can affect anyone regardless of age, and it often starts during late teens or early adulthood. Although some patients with MDD have an adequate response to medications, only approximately 50% respond to the first treatment, and approximately 30% do ...
Parna Haghparast, PharmD, BCPS, Busuyi Olotu, BPharm, MSPharm, PhD, Carol Yuan, PharmD, BCPP   +2 more
doaj   +1 more source

Integrative PheWAS analysis in risk categorization of major depressive disorder and identifying their associations with genetic variants using a latent topic model approach

Translational Psychiatry, 2022
Major depressive disorder (MDD) is the most prevalent mental disorder that constitutes a major public health problem. A tool for predicting the risk of MDD could assist with the early identification of MDD patients and targeted interventions to reduce ...
Xiangfei Meng, Michelle Wang, Kieran J. O’Donnell, Jean Caron, Michael J. Meaney, Yue Li   +5 more
doaj   +1 more source

A MDD Strategy for developing Context-Aware Pervasive Systems [PDF]

, 2011
This master thesis proposes a methodological approach to develop context-aware pervasive systems based on ontologies and the Model-Driven Development (MDD) guidelines.Serral Asensio, E. (2008).
Serral Asensio, Estefanía
core   +1 more source

Pre- and post-COVID 19 outbreak relationship between physical activity and depressive symptoms in Spanish adults with major depressive disorder: a secondary analysis of the RADAR-MDD cohort study [PDF]

Aim: To evaluate the longitudinal association of sedentary behavior, light and moderate-to-vigorous physical activity (MVPA) participation with depressive symptoms and whether their possible association changed depending on the pandemic phase.
Lamers, Femke, Giné Vázquez, Iago, Ibáñez Salvador, Delia, Gardeñes, Lluisa, Hotopf, Matthew, Vázquez, Iago Giné, Condominas, Elena, Kontaxis, Spyridon, Peñarrubia-Maria, Maria Teresa, Narayan, Vaibhav, RADAR-MDD-Spain, Llaosa Scholten, Raúl, Arranz, Belen, Bailón, Raquel, García Pagès, Esther, Matcham, Faith, Lima, Rodrigo Antunes, Ibáñez, Delia, Garcia, Esther, Llaosa-Scholten, Raúl, Annas, Peter, Peñarrubia Maria, Maria Teresa, consortium, the RADAR CNS, Siddi, Sara, Condominas i Casanovas, Elena, Bailón Luesma, Raquel, Haro, Josep Maria, Penninx, Brenda W. J. H., ?, ?, Penninx, Brenda W J H, Penninx, Brenda, Antunes Lima, Rodrigo, Folarin, Amos   +32 more
core   +2 more sources

Involvement of gut microbiota in neuropsychiatric disorders and its therapeutic potential

Journal of Animal Reproduction and Biotechnology
Accumulating evidence indicates that the gut microbiota plays a pivotal role in overall health through complex interactions along the gut-brain axis. The present study explores the intricate relationships between the gut microbiota and the gut-brain axis,
Sangmin Lee, Gyebin Lee, Yeung Bae Jin, Han-Na Kim, Joo Hyung Park, Hye Jin Cha   +5 more
doaj   +1 more source

MEP-LINCS/MDD: Code release for publication [PDF]

, 2022
Molecular Deep Dive prepocessing and analysis ...
Mark Dane, mcleania
core   +1 more source

A Pilot Study of Symptoms of Major Depressive Disorder in Medical Students at an Osteopathic Medical School Before and After High-Stakes Examinations

Advances in Medical Education and Practice, 2023
Taxiarhia J Arabatzis,1 Justin Doroshenko,2 Muhammad A Ashraf,3 Ryan M Smith4 1Department of Internal Medicine-Pediatrics Residency Program, Geisinger Medical Center, Danville, PA, USA; 2Department of Emergency Medicine Residency Program, University of ...
Arabatzis TJ, Doroshenko J, Ashraf MA, Smith RM   +3 more
doaj  

Potential value of serum brain-derived neurotrophic factor, vascular endothelial growth factor, and S100B for identifying major depressive disorder in knee osteoarthritis patients

Frontiers in Psychiatry, 2022
BackgroundThe chronic pain and functional limitations in osteoarthritis (OA) patients can increase risk of psychiatric disorders, e.g., major depression disorder (MDD), which may further aggravate the clinical symptoms of OA.
Peng Zhang, Yuyuan Xiong, Bangjun Wang, Yi Zhou, Zijian Wang, Jiaqi Shi, Chao Li, Xinyan Lu, Gang Chen   +8 more
doaj   +1 more source

Antipsychotics in child and adolescent patients with major depressive disorder: A retrospective analysis of prescribing patterns [PDF]

Mental Health Clinician
Introduction Depression rates in children/adolescents in the United States have increased in the last 10 years. Fluoxetine and escitalopram are the only 2 antidepressants approved for the treatment of major depression disorder (MDD) in children ...
Danielle Dauchot, PharmD, Suzanne Rettey, PharmD, MPA, BCPP, Brittany L. Melton, PharmD, PhD, Karen E. Moeller, PharmD, BCPP   +3 more
doaj   +1 more source

Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study [PDF]

, 2017
Diego Novick,1 William Montgomery,2 Ellen Vorstenbosch,3 Maria Victoria Moneta,3 Héctor Dueñas,4 Josep Maria Haro3 1Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia; 3Parc Sanitari Sant
Novick D, Dueñas H, Vorstenbosch E, Montgomery W, Moneta MV, Haro JM   +5 more
core